Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 35AstraZeneca

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DURVALUMAB

Brand Name : IMFINZI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50MG/ML

Packaging :

Approval Date :

Application Number : 761069

Regulatory Info :

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date : 21/09/2018

Application Number : 20170905000017

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumabum

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 120mg/2.4ml

Packaging :

Approval Date : 11/06/2018

Application Number : 66548

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumabum

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 500mg/10ml

Packaging :

Approval Date : 11/06/2018

Application Number : 66548

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DURVALUMAB

Brand Name : IMFINZI

Dosage Form : SOLUTION

Dosage Strength : 50MG/ML

Packaging : 2.4ML/10ML

Approval Date :

Application Number : 2468816

Regulatory Info : Schedule D

Registration Country : Canada

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi 120 mg

Dosage Form : INF

Dosage Strength : 50mg/ml

Packaging : 2.4X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi 500 mg

Dosage Form : INF

Dosage Strength : 50mg/ml

Packaging : 10X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank